Product category:
Information Services, Databases
News Release from: Frost and Sullivan
Edited by the Processingtalk Editorial
Team on 22 December 2003
Product of the Year Award for Degussa
Revolutionary L-hydantoinase enzymatic process wins Degussa the 2003 Frost and Sullivan Product of the Year Award for the fine chemicals industry
Revolutionary L-hydantoinase enzymatic process wins Degussa the 2003 Frost and Sullivan product of the year award The 2003 Frost and Sullivan product of the year award for the fine chemicals industry is awarded to Degussa for its L-hydantoinase enzymatic process for single-step production of L-amino acids used in the pharmaceutical, food and chemical industry
This article was originally published on Processingtalk on 7 Feb 2003 at 8.00am (UK)
Related stories
The HIV/AIDS Therapies Market
While antiretroviral drugs in existing categories continue to be the mainstay of the HIV/AIDS therapies market in the United States, the development of new drugs offers exciting growth prospects
The European breast cancer pharmaceuticals market
The quest for a breast cancer wonder drug, and improved survival rates, continue to pump up business in the breast cancer pharmaceutical industry
Prior to hydantoinase technology, non-natural L-amino acids could only be obtained through a complex chemical process that consumed excessive amounts of energy and chemicals.
Backed by an established record of product innovation, the award recipient successfully responded to consumer demand for a simpler, more effective process.
Collaborating with Prof C Syldatk, a pioneer in the hydantoinase field at University of Stuttgart, and Prof F H Arnold a chemistry professor at Caltech, Degussa designed and developed a highly versatile platform technology based on tailor-made whole cell biocatalyst that convert 5-monosubstituted hydantoins into either an L- or D-amino acids in one pot with up to 100 percent chemical and optical yield.
Further reading
Proteomics sample preparations markets
Integrated, customised, and validated research solutions for proteomics analyses and drug discoveries will fuel growth in the sample preparations market, according to the latest market resaerch report
Portfolio management in pharmaceutical market
Portfolio management carves a niche for itself in the resource-constrained pharmaceutical market, based on the need to identify and prioritise the most profitable projects in the R and D pipeline
Pharma rethinks traditional product marketing
A resurgent disease management sector will compel pharmaceutical companies to market products as constituents of packages of care, re-directing their sales efforts towards planners rather than doctors
"Proteinogenic L-amino acids made in this way have enormous advantages.
The process is easy, efficient and costs involved are minimal which has given Degussa enormous advantages over its competitors," explains Frost and Sullivan Research Analyst, Dr Raju Adhikari.
Degussa has already won significant contracts to manufacture amino acids using L-hydantoinase enzymatic process and has several project tie-ups with both big and small pharmaceutical companies.
The company now possesses a clear competitive advantage in the market.
Strong in-house R and D supported by a budget in excess of USD47 million has underpinned the Degussa trailblazing product development efforts.
The visionary 'Project House System' has a strategic research orientation and is deeply involved in exploring technologies with future potential.
It has encouraged closer interaction of different business units for project discussion and growth-oriented R and D planning.
"Degussa success is not only based on its good track record on traditional manufacturing applications, but also on solid R and D and its prestigious background of being an innovator," notes Dr Adhikari.
"Degussa will continue to be a leader in the field".
Selection of the Frost and Sullivan award winner was based on extensive primary research among market participants, customers and suppliers as well as on secondary and technology research.
Industry participants were ranked based on specific measurement criteria that included degree of product innovation, product price and quality, estimated market penetration rate, acceptance of the product by intended users and competitive advantage of new product in industry.
By excelling against these criteria, and emerging as "the company that has best demonstrated the ability to develop and/or advance products with more innovative capabilities than competing vendors and products," Degussa was the undisputed choice for the 2003 Frost and Sullivan Product of the Year Award.
• Frost and Sullivan: contact details and other news
• Email this article to a colleague
• Register for the free Processingtalk email newsletter
• Processingtalk Home Page
Search the Pro-Talk network of sites
